UnknownPhase 2/3

Effect of Vitamin K 2 on Vascular Calcification in Hemodialysis Patients

Egypt60 participantsStarted 2019-09-01

Plain-language summary

The aim of this study is to assess the effect of supplementation of vitamin K2 (menaquinone, MK-7) and cholecalciferol (inactive vitamin D) on circulating levels of calcification regulators and to assess their safety in pediatric patients on regular hemodialysis patients.

Who can participate

Age range6 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Patients aged 6-18 years * Patients on hemodialysis since 3 months or longer * Hemodialysis frequency 3 times or more weekly Exclusion criteria: * Patients with life expectancy \< 3 months * Patients taking warfarin * Patients with known intestinal malabsorption

What they're measuring

Uncarboxylated MGP

Timeframe: 4 months

Uncarboxylated osteocalcin

Timeframe: 4 months

Trial details

NCT IDNCT04145492

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-01-01

View on ClinicalTrials.gov More End Stage Renal Disease trials